Using theta burst stimulation to improve motor function in Tourette Syndrome
Official title: Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome
Run by Children's Hospital Medical Center, Cincinnati · NCT05628805 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether a new brain stimulation technique can help young people with Tourette Syndrome improve their motor skills.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 10 Years to 21 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Trial ID | NCT05628805 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 10-21 years with a DSM-5 diagnosis of Tourette Syndrome who are clinically stable.
✕Probably not a fit
Patients with additional neurodevelopmental or psychiatric conditions beyond Tourette Syndrome, ADHD, or mild anxiety may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the effects of intermittent theta-burst stimulation (iTBS) on the motor system in patients with Tourette Syndrome (TS). By utilizing a sham-controlled protocol, the researchers will modulate the output of the pre-supplementary motor area (pre-SMA) to enhance inhibitory control in the motor system. The study focuses on participants aged 10-21 years who have a confirmed diagnosis of TS and are clinically stable. The non-invasive nature of TMS allows for a quick stimulation process, potentially leading to improved motor function in TS patients.
Why it matters
Potential benefit: If successful, this approach could significantly enhance motor inhibition in patients with Tourette Syndrome, improving their quality of life.
How similar studies have gone: While the use of TMS in treating Tourette Syndrome is a relatively novel approach, similar studies have shown promise in modulating brain circuits for other neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants of any sex, race, or ethnicity meeting all criteria listed below will be included in the study: 1. Aged 10-21 years 2. Fluent in English 3. DSM-5 diagnosis of TS, confirmed by the clinical team 4. Able to participate in the informed consent process, provide voluntary informed consent/assent and provide a spontaneous narrative description of the key elements of the study. 5. Clinical stability: determined by a physician, no switch of psychotropic medications or increase in dosage in the last 14 days from TMS treatment start; no change in other therapeutic interventions in last 14 days from TMS treatment start. Exclusion Criteria: 1. Any neurodevelopmental, psychiatric condition other than TS, ADHD, or OCD, or mild anxiety based on review of K-SADS. Note - if an exclusionary psychiatric diagnosis is suspected based on K-SADS, the research physician will follow up with the parent and referral will be made to psychology or psychiatry as appropriate. 2. Presence of metallic foreign bodies or implanted medical devices. 3. Not meeting inclusion criteria as described above 4. Non-fluency in English, as English is the language in the validated clinical questionnaires, and the participant must be able to understand real-time instructions from the study staff
Where it's running
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting
Study contacts
- Study coordinator: Molly Griffith
- Email: molly.griffith@cchmc.org
- Phone: 513-636-9669
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing Sertraline and Placebo for Treating Anxiety in Children with Neurodevelopmental Disorders
This study is testing if the medication sertraline can help reduce anxiety in children and teens aged 8-17 with neurodevelopmental disorders like autism and Fragile X syndrome compared to a placebo.
-
Cognitive-psychophysiological therapy, with or without biofeedback, for tics in young people with Tourette's
This project tests whether adding biofeedback to cognitive-psychophysiological therapy helps reduce tics in 14–21-year-olds with Tourette's.
-
Understanding premonitory urges during tic treatment with Habit Reversal Training
This study is testing how kids and teens with Tourette Disorder experience changes in their urges to tic while they try a treatment called Habit Reversal Training.
-
Nature- and activity-based group programs for neurodivergent children and youth in Agder
This project will try outdoor and activity-based group programs to see if they help children and teens with ADHD, autism, Tourette's, and related neurodivergent challenges feel better, gain confidence, and do better in daily life.
-
Study of brain activity in patients with Tourette Syndrome
This study is testing how brain activity changes in adults with severe Tourette Syndrome who are getting deep brain stimulation to better understand their tics.
-
Personalized deep brain stimulation for Tourette syndrome
This study is testing if personalized deep brain stimulation can help people with Tourette syndrome reduce their tics and improve related issues like anxiety and attention problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.